NIH Funding Opportunities
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 3 hours 56 min ago
Notice of NIAAA's participation in PAR-19-133, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15-Clinical Trial Not Allowed)
Notice NOT-AA-19-001 from the NIH Guide for Grants and Contracts
Notice of NIAAA's participation in PAR-19-135, Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
Notice NOT-AA-19-003 from the NIH Guide for Grants and Contracts
Notice of NIAAA's participation in NOT-OD-19-040 "Notice of Interest in Long-term Maintenance of Behavior Change Research"
Notice NOT-AA-19-004 from the NIH Guide for Grants and Contracts
Notice of Change Application Due Date(s) for RFA-HD-19-024 "Womens HIV Epidemiology Cohort Studies (R01 - Clinical Trial Not Allowed)"
Notice NOT-HD-19-002 from the NIH Guide for Grants and Contracts
Notice of Clarification of Eligibility for PAR-19-114 "Non-human Primates Facilities to Support HIV/AIDS-related Research (C06) (Clinical Trial Not Allowed)"
Notice NOT-OD-19-061 from the NIH Guide for Grants and Contracts
Notice of Clarification: Funds Available for RFA-DE-19-009 Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)
Notice NOT-DE-18-029 from the NIH Guide for Grants and Contracts
Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial Optional)
Funding Opportunity PA-19-166 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support research that uses evidence-based practical approaches to increase uptake of shared decision making (SDM) into routine clinical practice. To determine how to implement SDM in pragmatic settings, several areas will need to be addressed such as how to best engage patients/surrogates in the decision process; how to identify when and for whom decisions are needed; how to educate/train physicians and non-physician providers about both the importance of SDM and how to do it; how to use EHRs and other technologies to identify patients who need to make decisions, and how to capture SDM encounters and outputs; and how to incorporate SDM encounters into the clinical workflow without undue burden on staff or patients. Proposed projects will be required to consider using existing SDM evidence, knowledge, and approaches, tools, and curricula to the extent feasible. This initiative will require multi-disciplinary teams to conduct pragmatic research in clinical practice settings and other relevant settings such as community or public health clinics. Research teams should address patient, provider, contextual, and systems level factors including, but not limited to, healthcare provider education; patients with low health literacy skills; electronic healthcare record requirements to support SDM execution; clinical workflow issues that impede implementation of SDM; evaluation of SDM; and need for sustainable health care teams and models to implement SDM in real-world settings.
Notice of Intent to Publish a Funding Opportunity Announcement for Medical Rehabilitation Research Resource (P2C Clinical Trial Optional)
Notice NOT-HD-18-026 from the NIH Guide for Grants and Contracts
Notice of Clarification: Funds Available for RFA-DE-19-008 Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed)
Notice NOT-DE-18-028 from the NIH Guide for Grants and Contracts
Notice of NIAAA's participation in PAR-19-134, Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Notice NOT-AA-19-002 from the NIH Guide for Grants and Contracts
Notice of Change: Emphasizing Opportunity for Developing Comprehensive Human Genome Sequencing Methodologies in Response to NHGRI Novel Nucleic Acid Sequencing Technology Development FOAs
Notice NOT-HG-19-011 from the NIH Guide for Grants and Contracts
Notice of Modifications to Instructions for Letters of Support in PAR-19-102 "Graduate Research Training Initiative for Student Enhancement (RISE) (T32)"
Notice NOT-GM-19-017 from the NIH Guide for Grants and Contracts
The National Institutes of Health (NIH) Sexual and Gender Minority Research Office (SGMRO) Announces Pacific Regional Workshop on Sexual and Gender Minority (SGM)-Related Research
Notice NOT-OD-19-064 from the NIH Guide for Grants and Contracts
Notice of Change to Application Types for PAR-18-696, "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)"
Notice NOT-AT-19-016 from the NIH Guide for Grants and Contracts
Notice NOT-MH-19-010 from the NIH Guide for Grants and Contracts
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/44 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-18-023 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of novel and supportive technologies for the improvement of cell replacement interventions using novel methods, biomaterials and devices for type 1 diabetes (T1D) treatment.
Notice of Extension of the Response Date for NOT-HL-18-660 "Request for Information (RFI): Understanding the Health of Women and the Role of Sex/Gender in Mechanisms of Heart, Lung, Blood, and Sleep Diseases and Disorders"
Notice NOT-HL-19-672 from the NIH Guide for Grants and Contracts
Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)
Funding Opportunity PA-19-165 from the NIH Guide for Grants and Contracts. The Office of Research on Women's Health (ORWH) announces the availability of administrative supplements to support research highlighting the impact of sex/gender influences in human health and illness, including basic, preclinical, clinical, translational, and behavioral studies. Of special interest are studies relevant to understanding the significance of biological sex on cells and tissue explants; comparative studies of male and female tissues, organ systems and physiological systems; sex-based comparisons of pathophysiology, biomarkers, gene expression, clinical presentation and prevention and treatment of diseases. The most robust experimental designs include consideration of both sex and gender; therefore, applications proposing to investigate the influence of both sex and gender factors are highly encouraged. The proposed research must address at least one objective from Goals 1 through 5 of the new 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women".
Notice of Clarification of the Percent Effort for PAR-18-679 NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
Notice NOT-AI-19-034 from the NIH Guide for Grants and Contracts
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
Funding Opportunity RFA-MD-19-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to conduct innovative research supporting the development of a product, tool, technology, process or service for commercialization with the aim of eliminating disparities in socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minority populations or improving health in racial/ethnic minority populations.
NIH Funding Opportunities
- Development, Implementation, and Management of a Funding System to support the Grade A Milk Safety Program and National Shellfish Sanitation Program (U18)
- Notice of Correction to RFA-CA-19-008 "The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trial Not Allowed)"
- Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional)
- Notice of Removal of Matching Requirement Instructions for RFA-EB-18-003 "HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)"
- Notice of Intent to Publish a Funding Opportunity Announcement for Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed)